Donafenib, also known as CM-4307, is an oral multikinase inhibitor that targets Raf kinase and receptor tyrosine kinases with potential anticancer acivity. Donafenib is under clinical trials in China in patients with advanced hepatocellular carcinoma (HCC).
MedKoo Cat#: 124806
Name: Donafenib tosylate
CAS#: 1333386-17-6 (tosylate)
Chemical Formula: C28H21D3ClF3N4O6S
Exact Mass: 0.0000
Molecular Weight: 640.05
Elemental Analysis: C, 52.54; H, 4.25; Cl, 5.54; F, 8.90; N, 8.75; O, 15.00; S, 5.01
The following data is based on the product molecular weight 640.05 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |